...
首页> 外文期刊>Archives of Clinical and Experimental Surgery >Central corneal thickness in children with adenotonsillary hypertrophy
【24h】

Central corneal thickness in children with adenotonsillary hypertrophy

机译:小儿腺扁桃体肥大的中央角膜厚度

获取原文
           

摘要

Aim: We aimed to detect whether the central corneal thickness value in children with advanced phase ATH (it is indicated with OSAS at large extent ) becomes different from that of children of the same age. Materials and Method: Prepubertal, nonobese, 6-12 years of age children were included in the study. The first group con- sisted of 15 patients (mean age, 8.13 ± 1.6 years; body index, 19.43 ± 2.11), and the second group consisted of 42 patients (mean age, 8.65 ± 2.7 years; body mass index 20.93 ± 5.71). The control group consisted of 31 subjects. Comprehensive otolaryngologic examinations of all children were done by an otolaryngologist. Following tonasal endoscopy, the levels of adenoid hypertrophy were graded from 1 towards 4 according to the criteria of Cassano et al., i.e., grade 1 as 25%, grade 2 as 25-50 %, grade 3 50-75%, and grade 4 over 75% were evaluated as adenoid hypertrophy making airway ob- struction. Tonsillary hypertrophy was graded using the Brodsky scale. Tonsillar size was graded as follows: grade 1, small tonsils confined to the tonsillar pillors; grade 2, tonsils extended just outside the pillors; grade 3, tonsils extended outside the pillors but did not meet at the midline; grade 4, large tonsils met at the midline. The patients whose adenoid and tonsil hypertrophies became grade 3 and 4 were evaluated as advanced level ATH, and they were included in the study. After the complications of all the patients were evaluated, visual acuity, measurement of intra eye-pressure and biomicroscopyand fundus treatment were performed. Central corneal thickness (CCT) of the patients was measured under topical anesthesia using an ultrasonic packmetry device. Results: There was no statistically significant distinction among all groups according to the results obtained by Duncan?s multiple comparison procedure ( p>0.01 ). Conclusions: We could not find a statistically significant distinction between the corneal thickness and ATH. Further stud- ies in more advanced age groups or using a wider range of patients series will test whether this result is also observed in the children who have been exposed to the disease for longer periods of time.
机译:目的:我们的目的是检测晚期ATH儿童(在很大程度上由OSAS指示)与同龄儿童的中央角膜厚度值是否有所不同。材料和方法:这项研究包括青春期前,非肥胖,6-12岁的儿童。第一组由15名患者组成(平均年龄8.13±1.6岁;身体指数为19.43±2.11),第二组由42名患者组成(平均年龄为8.65±2.7岁;体重指数为20.93±5.71) 。对照组由31名受试者组成。耳鼻喉科医生对所有儿童进行了全面的耳鼻喉科检查。鼻内窥镜检查后,根据Cassano等人的标准,将腺样体肥大的级别从1分级为4,即1级为25%,2级为25-50%,3级为50-75%,3级超过75%的4个被评估为腺样体肥大,造成气道阻塞。使用Brodsky量表对扁桃体肥大进行分级。扁桃体大小分级如下:1级,局限于扁桃体药丸的小扁桃体;扁桃体2级,仅在药丸外延伸; 3级,扁桃体向外延伸,但未在中线汇合; 4年级,大扁桃体在中线相遇。将腺样体和扁桃体肥大程度达到3级和4级的患者评估为晚期ATH,并将其纳入研究。在评估所有患者的并发症后,进行视力检查,眼内压测量以及生物显微镜和眼底治疗。使用超声包装仪在局部麻醉下测量患者的中央角膜厚度(CCT)。结果:根据邓肯多重比较程序获得的结果,所有组之间均无统计学差异(p> 0.01)。结论:我们在角膜厚度和ATH之间找不到统计学上显着的区别。在更高年龄组或使用更多患者系列的进一步研究将测试在长时间接触该疾病的儿童中是否也观察到该结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号